- Medical School - The Ohio State University College of Medicine (1998-2002)
- Fellowship - Mayo Clinic College of Science and Medicine (2007-2008), Multiple Sclerosis
- Fellowship - Mayo Clinic College of Medicine and Science (2006-2007), Behavioral Neurology
- Residency - Cleveland Clinic Foundation (2003-2006), Neurology
- Internship - Cleveland Clinic Foundation (2002-2003), Internal Medicine
Brendan Kelley, M.D.
Vice Chair for Clinical Operations
- Memory Disorders
- Alzheimer's Disease
Brendan Kelley, M.D., is a Professor and Clinical Vice-Chair in the Department of Neurology at UT Southwestern Medical Center. He specializes in the evaluation and study of neurological causes of impairment in memory and cognition.
Dr. Kelley earned his medical degree at The Ohio State University. He completed a residency in neurology at the Cleveland Clinic and received advanced training in behavioral neurology and multiple sclerosis through fellowships at the Mayo Clinic.
He also holds an executive M.B.A. from The Ohio State University’s Fisher College of Business and a master’s degree in physics from Cornell University.
Certified by the American Board of Psychiatry and Neurology, he joined the UT Southwestern faculty in 2017.
Dr. Kelley’s research focuses on the clinical translation of novel techniques to better identify changes in the brain and spinal fluid related to Alzheimer’s disease and other dementias. He collaborates with investigators in UT Southwestern research labs who conduct basic science research to better understand the biological processes that cause neurodegeneration and to improve our ability to detect these changes before irreversible cognitive impairments have occurred.
He also participates in clinical research trials conducted throughout the United States that are aimed at testing new compounds as potential treatments for dementia. He has authored numerous peer-reviewed scientific articles and book chapters related to Alzheimer’s disease and other dementias.
Dr. Kelley directs the UT Southwestern Behavioral Neurology and Neuropsychiatry Fellowship Program. He’s a member of the American Neurological Association and the Behavioral Neurology Section of the American Academy of Neurology.
- American Neurological Association
- American Academy of Neurology
- APP Champion of the Year 2020, UT Southwestern
- Buckeye Pride Award for Patient Satisfaction 2015-2017
- Columbus Monthly Top Doctors 2015-2016
- Cincinnati Magazine Top Doctors 2010-2014
- AAN Award for Excellence in Clinical Neurology 2002
- OSU Neurology Department Award for Outstanding Performance 2002
- J.D. and C.D. Smith Award 1995, The Ohio State University
- Excellence in Teaching Award 1995, The Ohio State University Department of Physics
- Graduated Summa Cum Laude 1995, The Ohio State University
- Outstanding Scholar in the College of Humanities 1993, The Ohio State University
- Phi Beta Kappa 1992, The Ohio State University
Cognitive impairment in acute cocaine withdrawal.
Kelley BJ, Yeager KR, Pepper TH, Beversdorf DQ Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2005 Jun 18 2 108-12
Performance of the NINDS-CSN 5-minute protocol in a national population-based sample.
Kennedy RE, Wadley VG, McClure LA, Letter AJ, Unverzagt FW, Crowe M, Nyenhius D, Kelley BJ, Kana B, Marceaux J, Kurella Tamura M, Howard V, Howard G Journal of the International Neuropsychological Society : JINS 2014 Sep 20 8 856-67
Treatment of Mild Cognitive Impairment.
Kelley BJ Current treatment options in neurology 2015 Sep 17 9 372
C9ORF72 repeat expansions in cases with previously identified pathogenic mutations.
van Blitterswijk M, Baker MC, DeJesus-Hernandez M, Ghidoni R, Benussi L, Finger E, Hsiung GY, Kelley BJ, Murray ME, Rutherford NJ, Brown PE, Ravenscroft T, Mullen B, Ash PE, Bieniek KF, Hatanpaa KJ, Karydas A, Wood EM, Coppola G, Bigio EH, Lippa C, Strong MJ, Beach TG, Knopman DS, Huey ED, Mesulam M, Bird T, White CL, Kertesz A, Geschwind DH, Van Deerlin VM, Petersen RC, Binetti G, Miller BL, Petrucelli L, Wszolek ZK, Boylan KB, Graff-Radford NR, Mackenzie IR, Boeve BF, Dickson DW, Rademakers R Neurology 2013 Oct 81 15 1332-41
Prominent phenotypic variability associated with mutations in Progranulin.
Kelley BJ, Haidar W, Boeve BF, Baker M, Graff-Radford NR, Krefft T, Frank AR, Jack CR, Shiung M, Knopman DS, Josephs KA, Parashos SA, Rademakers R, Hutton M, Pickering-Brown S, Adamson J, Kuntz KM, Dickson DW, Parisi JE, Smith GE, Ivnik RJ, Petersen RC Neurobiology of aging 2009 May 30 5 739-51
Atypical motor and behavioral presentations of Alzheimer disease: a case-based approach.
Duker AP, Espay AJ, Wszolek ZK, Rademakers R, Dickson DW, Kelley BJ The neurologist 2012 Sep 18 5 266-72
Cognitive effects of statin medications.
Kelley BJ, Glasser S CNS drugs 2014 May 28 5 411-9
Regular aspirin use does not reduce risk of cognitive decline.
Kelley BJ, McClure LA, Unverzagt FW, Kissela B, Kleindorfer D, Howard G, Wadley VG Journal of the American Geriatrics Society 2015 Feb 63 2 390-2
Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management.
Kelley BJ, Rodriguez M CNS drugs 2009 Oct 23 10 805-15
Dopamine agonists and pathologic behaviors.
Kelley BJ, Duker AP, Chiu P Parkinson's disease 2012 2012 603631
Dramatic Benefits from Standard Work Implementation
Kelley BJ, Bellamy B, Haley R Journal Medical Practice Management 2018 33 6 378-382
Young-onset dementia: demographic and etiologic characteristics of 235 patients.
Kelley BJ, Boeve BF, Josephs KA Archives of neurology 2008 Nov 65 11 1502-8
Alternative medicine and Alzheimer disease.
Kelley BJ, Knopman DS The neurologist 2008 Sep 14 5 299-306
Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.
Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, Stewart H, Kelley BJ, Kuntz K, Crook RJ, Sreedharan J, Vance C, Sorenson E, Lippa C, Bigio EH, Geschwind DH, Knopman DS, Mitsumoto H, Petersen RC, Cashman NR, Hutton M, Shaw CE, Boylan KB, Boeve B, Graff-Radford NR, Wszolek ZK, Caselli RJ, Dickson DW, Mackenzie IR, Petrucelli L, Rademakers R PLoS genetics 2008 Sep 4 9 e1000193
Cognitive and noncognitive neurological features of young-onset dementia.
Kelley BJ, Boeve BF, Josephs KA Dementia and geriatric cognitive disorders 2009 27 6 564-71
Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin.
Kelley BJ, Haidar W, Boeve BF, Baker M, Shiung M, Knopman DS, Rademakers R, Hutton M, Adamson J, Kuntz KM, Dickson DW, Parisi JE, Smith GE, Petersen RC Archives of neurology 2010 Feb 67 2 171-7
Compressive myelopathy mimicking transverse myelitis.
Kelley BJ, Erickson BJ, Weinshenker BG The neurologist 2010 Mar 16 2 120-2
Vascular risk factors and cognitive impairment in a stroke-free cohort.
Unverzagt FW, McClure LA, Wadley VG, Jenny NS, Go RC, Cushman M, Kissela BM, Kelley BJ, Kennedy R, Moy CS, Howard V, Howard G Neurology 2011 Nov 77 19 1729-36
Chronic Use of Aspirin and Total White Matter Lesion Volume: Results from the Women's Health Initiative Memory Study of Magnetic Resonance Imaging Study.
Holcombe A, Ammann E, Espeland MA, Kelley BJ, Manson JE, Wallace R, Robinson J Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2017 May
Electronic Transport Characterization of HEMT Structures
Kelley BJ, Dodrill B, Lindemuth J, Du G, Meyer J, Faraone L Solid State Technology 2000 43
Vascular Cognitive Impairment - Part 1
Zha AM, Kelley BJ Practical Neurology 2015 January/February
Detect GMR defects early with in-line metrology
Dodrill B, Kelley BJ DataStorage 2000 7 35-46
Alzheimer's disease and mild cognitive impairment.
Kelley BJ, Petersen RC Neurologic clinics 2007 Aug 25 3 577-609, v
Bilingual problem-solving training for caregivers of adults with dementia: A randomized, factorial-design protocol for the CaDeS trial.
Juengst S, Supnet C, Kew CLN, Silva V, Vega M, Han G, Kelley B, Smith ML, Maestre G, Contemporary clinical trials 2021 Jul 108 106506
PRES following administration of DHE in a patient with unsuspected pheochromocytoma.
Kelley BJ, Samples S, Kunkel R Headache 2008 Sep 48 8 1237-9
The effect of propranolol on cognitive flexibility and memory in acute cocaine withdrawal.
Kelley BJ, Yeager KR, Pepper TH, Bornstein RA, Beversdorf DQ Neurocase 2007 Oct 13 5 320-7
Magnetic In-Line Metrology for GMR Spin-Valve Sensors
Dodrill B, Kelley BJ Datatech 1999 3 143-148
Vascular Cognitive Impairment ? Part 2
Zha AM, Kelley BJ Practical Neurology 2015 March
Rapidly progressive young-onset dementia.
Kelley BJ, Boeve BF, Josephs KA Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 2009 Mar 22 1 22-7
Evaluation of Multilayer Transport Properties using Quantitative Mobility Spectrum Analysis
Dodrill B, Lindemuth J, Kelley BJ, Du G, Meyer J Compound Semiconductor 2001 7 58-61
A middle-aged man with progressive neurologic deficits and bilateral leg lesions.
Kelley BJ, Samples S, Mays M Cleveland Clinic journal of medicine 2006 Mar 73 3 269-72
- Cognitive impairment in acute cocaine withdrawal.
- Mild Cognitive Impairment
- Alzheimer’s Disease
- Memory Disorders
- Alzheimer's Disease
- Lewy Body Dementia
- Frontotemporal Dementia